Recent Changes in Breast Cancer Incidence in Spain, 1980–2004
暂无分享,去创建一个
C. Navarro | M. Pollán | G. López-Abente | E. Ardanaz | R. Pastor-Barriuso | M. Chirlaque | N. Larranaga | A. Izquierdo | M. Sánchez-Pérez | J. Galceran | J. Borràs | R. Marcos-Gragera | M. Tobalina | M. Rabanaque | C. Martos | I. Garau | M. Argüelles | C. Martínez | J. Perucha | A. Mateos | Ruth Martínez-Cobo | María-Dolores Rojas-Martín | R. Jiménez | Maria-Eugenia Pérez-de-Rada | S. González | E. Hernandez | A. Torrella‐Ramos | Enrique Vidal
[1] J. Manson,et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. , 2009, The New England journal of medicine.
[2] Helen Farrugia,et al. Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia , 2009, The Medical journal of Australia.
[3] J. Otten,et al. Impressive time‐related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975‐2006 , 2008, International journal of cancer.
[4] M. Kumle. Declining breast cancer incidence and decreased HRT use , 2008, The Lancet.
[5] J. Marks,et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] J. Ferlay,et al. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[7] B. Macmahon,et al. Is the incidence of breast cancer declining? , 2008, Epidemiology.
[8] R. Rawal,et al. Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy , 2008, Breast Cancer Research and Treatment.
[9] D. Miglioretti,et al. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. , 2007, Journal of the National Cancer Institute.
[10] Robert N Hoover,et al. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.
[11] J. Daling,et al. Changes in Breast Cancer Incidence Rates in the United States by Histologic Subtype and Race/Ethnicity, 1995 to 2004 , 2007, Cancer Epidemiology Biomarkers & Prevention.
[12] J. Coebergh,et al. Does the decrease in hormone replacement therapy also affect breast cancer risk in the Netherlands? , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] J. Coebergh,et al. On the avoidability of breast cancer in industrialized societies: older mean age at first birth as an indicator of excess breast cancer risk , 2007, Breast Cancer Research and Treatment.
[14] Bingshu E. Chen,et al. Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers , 2007, Cancer Causes & Control.
[15] J. Bulliard,et al. Trends in breast cancer incidence among women under the age of forty , 2007, British Journal of Cancer.
[16] E. Kliewer,et al. A decline in breast-cancer incidence. , 2007, The New England journal of medicine.
[17] Michael J Thun,et al. Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women , 2007, Breast Cancer Research.
[18] Eric J Feuer,et al. The decrease in breast-cancer incidence in 2003 in the United States. , 2007, The New England journal of medicine.
[19] Bingshu E. Chen,et al. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions , 2007, Cancer Causes & Control.
[20] D. M. Parkin,et al. Use of Statistics to Assess the Global Burden of Breast Cancer , 2006, The breast journal.
[21] L. Serra-Majem,et al. [Prevalence of obesity in Spain]. , 2005, Medicina clinica.
[22] J. Aranceta-bartrina,et al. Prevalencia de obesidad en España , 2005 .
[23] A. Miller,et al. Age at menarche in relation to adult height: the EPIC study. , 2005, American journal of epidemiology.
[24] Kari Kuulasmaa,et al. Use of oral contraceptives and hormone replacement therapy in the WHO MONICA project. , 2004, Maturitas.
[25] Mark Garton,et al. Breast cancer and hormone-replacement therapy: the Million Women Study , 2003, The Lancet.
[26] F. Bray,et al. Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.
[27] Roberto Pastor-Barriuso,et al. Transition models for change‐point estimation in logistic regression , 2003, Statistics in medicine.
[28] A. Miller,et al. Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC) , 2002, Public Health Nutrition.
[29] C. Kooperberg,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.
[30] Hyune-Ju Kim,et al. Kim H-J, Fay MP, Feuer EJ, Midthune DN, ‘ Permutation tests for joinpoint regression with applications to cancer rates’. Statistics in Medicine 2000 19:335–351 , 2001 .
[31] E. Feuer,et al. Permutation tests for joinpoint regression with applications to cancer rates. , 2000, Statistics in medicine.
[32] Xavier Bosch,et al. barcelona Investigating the reasons for Spain's falling birth rate , 1998, The Lancet.
[33] J. Ferlay,et al. Cancer Incidence in Five Continents , 1997 .
[34] P. McCullagh,et al. Generalized Linear Models , 1992 .
[35] P. McCullagh,et al. Generalized Linear Models , 1984 .
[36] S D Walter,et al. Estimation of the duration of a pre-clinical disease state using screening data. , 1983, American journal of epidemiology.
[37] K. Worsley. An improved Bonferroni inequality and applications , 1982 .
[38] Books Received,et al. Notes , 1921, Nature.
[39] A. Weill,et al. [Decline in breast cancer incidence in 2005 and 2006 in France: a paradoxical trend]. , 2008, Bulletin du cancer.
[40] A. Weill,et al. Baisse de l’incidence des cancers du sein en 2005 et 2006 en France : un phénomène paradoxal , 2008 .
[41] L. Shulman. The Decrease in Breast-Cancer Incidence in 2003 in the United States , 2008 .
[42] S. Rosso,et al. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. , 2007, Journal of the National Cancer Institute.
[43] Carmen Rodríguez Blas. Encuesta Nacional de Salud , 2007 .
[44] G. Elfenbein. A decline in breast-cancer incidence. , 2007, The New England journal of medicine.
[45] Andrés Arroyo Pérez. Tendencias demográficas durante el siglo XX en España , 2003 .
[46] T. Vega Alonso,et al. [Hormonal replacement therapy in Spain]. , 2002, Medicina clinica.
[47] H. Schneider,et al. Cross-national study of women's use of hormone replacement therapy (HRT) in Europe. , 1997, International journal of fertility and women's medicine.
[48] J. Ferlay,et al. Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.